Steris Plc (NYSE: STE) started the day on Wednesday, with a price decrease of -0.35% at $266.85, before settling in for the price of $267.79 at the close. Taking a more long-term approach, STE posted a 52-week range of $200.98-$268.60.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 5.92%. Meanwhile, its Annual Earning per share during the time was 5.92%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.38%. This publicly-traded company’s shares outstanding now amounts to $98.10 million, simultaneously with a float of $97.82 million. The organization now has a market capitalization sitting at $26.19 billion. At the time of writing, stock’s 50-day Moving Average stood at $247.95, while the 200-day Moving Average is $236.57.
Steris Plc (STE) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Devices Industry. Steris Plc’s current insider ownership accounts for 0.33%, in contrast to 96.24% institutional ownership. According to the most recent insider trade that took place on Nov 21 ’25, this organization’s Sr. VP and GM, Life Sciences sold 5,008 shares at the rate of 262.00, making the entire transaction reach 1,312,096 in total value, affecting insider ownership by 10,710.
Steris Plc (STE) Earnings and Revenue Records
Steris Plc’s EPS increase for this current 12-month fiscal period is 9.38% and is forecasted to reach 11.13 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.57% through the next 5 years, which can be compared against the 5.92% growth it accomplished over the previous five years trading on the market.
Steris Plc (NYSE: STE) Trading Performance Indicators
Let’s observe the current performance indicators for Steris Plc (STE). It’s Quick Ratio in the last reported quarter now stands at 1.63. Alongside those numbers, its PE Ratio stands at $37.98, and its Beta score is 1.00. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.59. Similarly, its price to free cash flow for trailing twelve months is now 27.31.
In the same vein, STE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 7.03, a figure that is expected to reach 2.53 in the next quarter, and analysts are predicting that it will be 11.13 at the market close of one year from today.
Technical Analysis of Steris Plc (STE)
If we take a close look at the recent performances of Steris Plc (NYSE: STE), its last 5-days Average volume was 0.73 million that shows progress from its year to date volume of 0.61 million. During the previous 9 days, stock’s Stochastic %D was recorded 84.04% While, its Average True Range was 69.51.
Raw Stochastic average of Steris Plc (STE) in the period of the previous 100 days is set at 96.36%, which indicates a major rise in contrast to 89.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 5.05 that was higher than 4.44 volatility it exhibited in the past 100-days period.
